SEVERE WEAKNESS, SHORTNESS OF BREATH, MALAISE, TACHYCARDIA ATTACKS

A patient, born in 1966, was admitted in a severe condition complaining of extreme weakness, shortness of breath, malaise, tachycardia attacks relieved only by cardiac glycosides, severe restriction of mobility in all joints (hip, knee, ankle, shoulder, elbow, and wrist), with BP 180/120 then 160/100. She first became ill 5 years ago, has been repeatedly treated in hospital, and has received hormone therapy (25 mg prednisolone 3 times a day) for 3 years. Diagnosis: Rheumatism, activity I-II, recurrent rheumatic carditis, mitral-aortic defect, rheumatoid arthritis.

Treatment was conducted using the "INFRA R" RT method, with emitters providing anti-inflammatory effects and normalizing microcirculation. Simultaneously, procedures were carried out with the use of UICI aimed at normalizing lipid metabolism and gut microflora.

The patient underwent 2 treatment courses with a 2-week break. The first course lasted one month. The results of the first course included:

• Elimination of swelling in all joints
• Normalization of gastrointestinal function
• The patient could dress and move independently
• BP stabilized at 130/80
• Tachycardia attacks sharply decreased, almost disappearing.

After a two-week break, the patient returned for continued treatment, following the same scheme but with an emphasis on normalizing lipid metabolism and stimulating glucocorticoid synthesis.

Thanks to the treatment, the patient was taken off hormone therapy, became active, and could move freely.